Clinical Trial Update: Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update describing a switch from adefovir to tenofovir for chronic hepatitis B patients with suboptimal response to adefovir-based therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepsera (adefovir dipivoxil)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Yonsei University | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN